Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 10, 2026 17:01 ET | Source: First Quantum Minerals Ltd.

First Quantum Minerals Reports Fourth Quarter 2025 Results

TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- First Quantum Minerals Ltd. (“First Quantum” or the "Company”) (TSX: FM) today reports results for the three months and year-ended December 31, 2025 (“Q4...
February 10, 2026 08:30 ET | Source: RenovoRx, Inc.

RenovoRx Establishes RenovoCath® Medical Advisory Board

MOUNTAIN VIEW, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and...
February 09, 2026 10:31 ET | Source: Research and Markets

Organic Fertilizer Market Analysis Report 2025-2031: Europe Leads While Capacity Expansion and Subsidies Shift Growth Momentum Toward North America

Dublin, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The "Organic Fertilizer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" report has been added to ...
February 09, 2026 07:05 ET | Source: Zenas BioPharma

Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026

- Obexelimab met the primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo over weeks 8 and 12 (p=0.0009) - - Separately announced 24-week...
February 09, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia

The US and Japan granted breakthrough therapy/orphan status to rilzabrutinib for wAIHA, a rare blood disorder marked by the destruction of red blood cells
February 06, 2026 07:30 ET | Source: TG Therapeutics, Inc.

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy), to be presented at the Americas...
February 04, 2026 16:36 ET | Source: Magnera Corporation

Magnera Reports First Quarter Results

CHARLOTTE, N.C., Feb. 04, 2026 (GLOBE NEWSWIRE) -- First Quarter Highlights GAAP: Net sales of $792 million, Operating income of $14 millionNon-GAAP: Adjusted EBITDA of $93 millionFiscal 2026...
February 04, 2026 15:15 ET | Source: Garaherb

Garaherb Unveiled: How This Garaherb Male Supplement Sets New Standards in Men’s Health & Daily Wellness Support

Intro New York City, NY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- In response to growing global attention on proactive men’s wellness and age-related vitality support, Garaherb has emerged in 2026 as a...
February 04, 2026 11:16 ET | Source: BCC Research LLC

Bioprocess Filtration Industry Set for 13.1% CAGR Growth, Reaching $15.6 Billion by 2030

“Bioprocess Filtration: Global Markets” is estimated to grow from $8.4 billion in 2025 to $15.6 billion by 2030, at a CAGR of 13.1% from 2025 through 2030.
February 04, 2026 09:00 ET | Source: EmpowerFresh

EmpowerFresh Announces New Partnership with Karns Quality Foods

Kansas City, MO., Feb. 04, 2026 (GLOBE NEWSWIRE) -- EmpowerFresh, the leading AI-powered produce intelligence and ordering platform for independent grocers, is proud to announce a new partnership...